These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 24961372)

  • 1. Macrolide antibiotics allosterically predispose the ribosome for translation arrest.
    Sothiselvam S; Liu B; Han W; Ramu H; Klepacki D; Atkinson GC; Brauer A; Remm M; Tenson T; Schulten K; Vázquez-Laslop N; Mankin AS
    Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9804-9. PubMed ID: 24961372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Context-specific action of macrolide antibiotics on the eukaryotic ribosome.
    Svetlov MS; Koller TO; Meydan S; Shankar V; Klepacki D; Polacek N; Guydosh NR; Vázquez-Laslop N; Wilson DN; Mankin AS
    Nat Commun; 2021 May; 12(1):2803. PubMed ID: 33990576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel.
    Kannan K; Vázquez-Laslop N; Mankin AS
    Cell; 2012 Oct; 151(3):508-20. PubMed ID: 23101624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics.
    Beckert B; Leroy EC; Sothiselvam S; Bock LV; Svetlov MS; Graf M; Arenz S; Abdelshahid M; Seip B; Grubmüller H; Mankin AS; Innis CA; Vázquez-Laslop N; Wilson DN
    Nat Commun; 2021 Jul; 12(1):4466. PubMed ID: 34294725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of antibiotic ligand in nascent peptide-dependent ribosome stalling.
    Vázquez-Laslop N; Klepacki D; Mulhearn DC; Ramu H; Krasnykh O; Franzblau S; Mankin AS
    Proc Natl Acad Sci U S A; 2011 Jun; 108(26):10496-501. PubMed ID: 21670252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosomal tunnel and translation regulation.
    Bogdanov AA; Sumbatyan NV; Shishkina AV; Karpenko VV; Korshunova GA
    Biochemistry (Mosc); 2010 Dec; 75(13):1501-16. PubMed ID: 21417991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of drug-ribosome interactions defines the cidality of macrolide antibiotics.
    Svetlov MS; Vázquez-Laslop N; Mankin AS
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13673-13678. PubMed ID: 29229833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition.
    Starosta AL; Karpenko VV; Shishkina AV; Mikolajka A; Sumbatyan NV; Schluenzen F; Korshunova GA; Bogdanov AA; Wilson DN
    Chem Biol; 2010 May; 17(5):504-14. PubMed ID: 20534348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugates of amino acids and peptides with 5-o-mycaminosyltylonolide and their interaction with the ribosomal exit tunnel.
    Shishkina A; Makarov G; Tereshchenkov A; Korshunova G; Sumbatyan N; Golovin A; Svetlov M; Bogdanov A
    Bioconjug Chem; 2013 Nov; 24(11):1861-9. PubMed ID: 24090034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward the rational design of macrolide antibiotics to combat resistance.
    Pavlova A; Parks JM; Oyelere AK; Gumbart JC
    Chem Biol Drug Des; 2017 Nov; 90(5):641-652. PubMed ID: 28419786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nascent peptide assists the ribosome in recognizing chemically distinct small molecules.
    Gupta P; Liu B; Klepacki D; Gupta V; Schulten K; Mankin AS; Vázquez-Laslop N
    Nat Chem Biol; 2016 Mar; 12(3):153-8. PubMed ID: 26727240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical 23S rRNA interactions for macrolide-dependent ribosome stalling on the ErmCL nascent peptide chain.
    Koch M; Willi J; Pradère U; Hall J; Polacek N
    Nucleic Acids Res; 2017 Jun; 45(11):6717-6728. PubMed ID: 28369621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting translational stalling peptides in an effort to extend azithromycin interaction within the prokaryotic ribosome nascent peptide exit tunnel.
    Washington AZ; Tapadar S; George A; Oyelere AK
    Bioorg Med Chem; 2015 Aug; 23(16):5198-209. PubMed ID: 26037612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Macrolide Antibiotics Work.
    Vázquez-Laslop N; Mankin AS
    Trends Biochem Sci; 2018 Sep; 43(9):668-684. PubMed ID: 30054232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The general mode of translation inhibition by macrolide antibiotics.
    Kannan K; Kanabar P; Schryer D; Florin T; Oh E; Bahroos N; Tenson T; Weissman JS; Mankin AS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(45):15958-63. PubMed ID: 25349425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Context-Specific Action of Ribosomal Antibiotics.
    Vázquez-Laslop N; Mankin AS
    Annu Rev Microbiol; 2018 Sep; 72():185-207. PubMed ID: 29906204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of gene expression by macrolide-induced ribosomal frameshifting.
    Gupta P; Kannan K; Mankin AS; Vázquez-Laslop N
    Mol Cell; 2013 Dec; 52(5):629-42. PubMed ID: 24239289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence selectivity of macrolide-induced translational attenuation.
    Davis AR; Gohara DW; Yap MN
    Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15379-84. PubMed ID: 25313041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Measurements of Erythromycin's Effect on Protein Synthesis Kinetics in Living Bacterial Cells.
    Seefeldt AC; Aguirre Rivera J; Johansson M
    J Mol Biol; 2021 May; 433(10):166942. PubMed ID: 33744313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
    Kannan K; Mankin AS
    Ann N Y Acad Sci; 2011 Dec; 1241():33-47. PubMed ID: 22191525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.